EU and AstraZeneca settle vaccine supply dispute - France 24 EU and AstraZeneca settle vaccine supply dispute France 24

The European Union and UK-based drugs giant AstraZeneca settled their dispute over a shortfall in coronavirus vaccine supplies on Friday, agreeing an extended delivery schedule.

The European Commission went to court after the firm failed to deliver all of a promised 300 million doses by June 2021, but AstraZeneca will now have until the end of March next year to make up the number.

Israel’s COVID-19 boosters are preventing infections, new studies suggest Protection increases in the weeks following a third dose, but it’s unclear how long the effect will last newsfromscience

Israel’s nationwide campaign to provide its population with COVID-19 vaccine boosters appears to benefit recipients. A third dose of the Pfizer-BioNTech vaccine significantly lowers the risk of infection, according to two new studies.

American Medical Association calls for 'immediate end' to use of The American Medical Association (AMA) is calling for the "immediate end" to the use of ivermectin to treat COVID-19, and for doctors to stop prescribing it for that purpose, amid a spike in the use Peter Sullivan TheHill

The American Medical Association (AMA) is calling for the "immediate end" to the use of ivermectin to treat COVID-19, and for doctors to stop prescribing it for that purpose, amid a spike in the use of the drug. 

Since the beginning of the pandemic, doctors have found that people who become very ill with Covid-19 often experience kidney problems, not just the lung impairments that are the hallmark of the illness.

Now, a large study suggests that kidney issues can last for months after patients recover from the initial infection, and may lead to a serious lifelong reduction of kidney function in some patients.

How Covid data gaps allowed Delta to proliferate Eighteen months into the pandemic, Louisiana and more than 20 other states are still trying to fill key gaps in data while fighting the most aggressive version yet of the virus. Erin Banco POLITICO

When new Covid-19 infections and hospitalizations began soaring in Louisiana in July, state health officials were struggling with data gaps that blinded them to the full threat of the Delta variant.